Skip to main content
SpringerLink
Log in

Acitretin/ruxolitinib

Acquired epidermodysplasia verruciformis (first report with ruxolitinib), squamous cell carcinoma and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Demirel Ogut N, et al. Possible ruxolitinib-induced acquired epidermodysplasia verruciformis and multiple non-melanoma skin cancers in a patient with polycythemia vera. Journal of Cosmetic Dermatology 21: 6502-6503, No. 11, Nov 2022. Available from: URL: http://doi.org/10.1111/jocd.15253

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acitretin/ruxolitinib. Reactions Weekly 1942, 16 (2023). https://doi.org/10.1007/s40278-023-32625-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32625-6

Search

Navigation